FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D
The aim: to study features of the cytokine profile in patients with chronic kidney disease receiving treatment by programmed hemodialysis. Materials and methods: the study included 100 patients aged 53,4 ± 15,8 years with chronic kidney disease stage 5D, receiving hemodialysis. All patients were per...
Saved in:
Main Authors: | E. S. Lapina (Author), M. M. Batjushin (Author), R. A. Belovolova (Author), I. V. Sarvilina (Author), V. N. Poganeva (Author) |
---|---|
Format: | Book |
Published: |
SINAPS LLC,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study
by: Yu‐Shan Huang, et al.
Published: (2022) -
Erythropoiesis-Stimulating Agents in the Management of Anemia in Chronic Kidney Disease or Cancer: A Historical Perspective
by: Matti Aapro, et al.
Published: (2019) -
Regulation of red cell life-span, erythropoiesis, senescence and clearance
by: Anna Bogdanova
Published: (2014) -
Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease
by: Mrittika Roy, et al.
Published: (2023) -
Erythropoiesis: insights into pathophysiology and treatments in 2017
by: Andrea Zivot, et al.
Published: (2018)